Literature DB >> 8425829

Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye.

L R Pasquale1, M E Dorman-Pease, G A Lutty, H A Quigley, H D Jampel.   

Abstract

PURPOSE: To determine the distribution of transforming growth factor type beta (TGF-beta) in the anterior segment of the human eye. This knowledge is important because TGF-beta may regulate various physiologic responses in the anterior segment by controlling cell proliferation and differentiation, angiogenesis, and extracellular matrix composition.
METHODS: Immunohistochemical methods were used to localize the beta 1, beta 2, and beta 3 isoforms of TGF-beta in the anterior segment of the human eye.
RESULTS: Eight of eight eyes (six eye bank specimens and two eyes enucleated because of choroidal melanoma) exhibited staining for at least one of the TGF-beta isoforms. TGF-beta 1 was found in superficial limbal epithelial cells (four of eight eyes) and in the stroma proximal to the ciliary processes (seven of eight eyes). TGF-beta 2 was found in superficial limbal epithelial cells (six of eight eyes), the conjunctival stroma (eight of eight eyes), in the ciliary processes (three of eight eyes), and in a diffuse distribution in the region of the radial and circular muscles of the ciliary body (eight of eight eyes). In addition, TGF-beta 2 was found in the stroma adjacent to the pigmented epithelium in the pars plana (eight of eight eyes). TGF-beta 3 was found in white blood cells in one of eight specimens; otherwise it was not found in the anterior segment. The corneal stroma, corneal endothelium, trabecular meshwork, iris, and ciliary epithelia did not exhibit immunoreactivity with the antibodies used in this study.
CONCLUSION: TGF-beta 1 and TGF-beta 2 have a distinct and specific distribution in the anterior segment of the adult human eye.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425829

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  52 in total

Review 1.  Role of cytokines in the pathogenesis of posterior capsule opacification.

Authors:  W R Meacock; D J Spalton; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model.

Authors:  Han Zhang; Zhe-Li Liu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 3.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

4.  Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells.

Authors:  Zhuo Chen; De-quan Li; Louis Tong; Paul Stewart; Claire Chu; Stephen C Pflugfelder
Journal:  Mol Vis       Date:  2006-08-23       Impact factor: 2.367

5.  Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes.

Authors:  Rupal H Trivedi; Matthew Nutaitis; David Vroman; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

6.  KGF, FGFb, VEGF, HGF and TGFβ1 secretion of human keratocytes following photodynamic inactivation (PDI) in vitro.

Authors:  Tanja Stachon; Jiong Wang; Timo Eppig; Achim Langenbucher; Markus Bischoff; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-08       Impact factor: 3.117

7.  The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes.

Authors:  S Pancholi; A Tullo; A Khaliq; D Foreman; M Boulton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

8.  Transforming growth factor beta-1 -509C>T polymorphism in Indian patients with primary open angle glaucoma.

Authors:  Sarangapani Sripriya; Ronnie George; Hemamalini Arvind; Mani Baskaran; Prema Raju; S V Ramesh; Tirumalai Karthiyayini; Lingam Vijaya; Govindasamy Kumaramanickavel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  The aqueous levels of TGF-beta2 in patients with glaucoma.

Authors:  Altan Atakan Ozcan; Nusret Ozdemir; Abdullah Canataroglu
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

10.  Responses of cultured human keratocytes and myofibroblasts to ethyl pyruvate: a microarray analysis of gene expression.

Authors:  Stephen A K Harvey; Emily Guerriero; Nahthai Charukamnoetkanok; Jordan Piluek; Joel S Schuman; Nirmala Sundarraj
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.